Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-26-022629
Filing Date
2026-05-13
Accepted
2026-05-13 09:00:49
Documents
57
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 1105844
2 EX-31.1 ex31-1.htm EX-31.1 18261
3 EX-31.2 ex31-2.htm EX-31.2 18481
4 EX-32.1 ex32-1.htm EX-32.1 7312
5 EX-32.2 ex32-2.htm EX-32.2 7270
  Complete submission text file 0001493152-26-022629.txt   5634587

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE cntn-20260331.xsd EX-101.SCH 45085
7 XBRL CALCULATION FILE cntn-20260331_cal.xml EX-101.CAL 36347
8 XBRL DEFINITION FILE cntn-20260331_def.xml EX-101.DEF 120162
9 XBRL LABEL FILE cntn-20260331_lab.xml EX-101.LAB 360265
10 XBRL PRESENTATION FILE cntn-20260331_pre.xml EX-101.PRE 251260
60 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1007023
Mailing Address 34 SHREWSBURY AVE SUITE 1C RED BANK NJ 07701
Business Address 1200 ROUTE 22 EAST BRIDGEWATER NJ 08807 302-743-2995
Canton Strategic Holdings, Inc. (Filer) CIK: 0001861657 (see all company filings)

EIN.: 842642541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41210 | Film No.: 26971174
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)